(Q44758267)

6 December 2017

title

Selective or nonselective endothelin receptor blockade in pulmonary arterial hypertension (English)

1 reference

6 December 2017

Martin R Wilkins

1

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

American Journal of Respiratory and Critical Care Medicine

6 December 2017

published in

1 reference

6 December 2017

volume

169

1 reference

6 December 2017

issue

4

1 reference

6 December 2017

page(s)

433-434

1 reference

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2312017

Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2312017

Beraprost therapy for pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2312017

Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2312017

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2312017

Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2312017

Serum uric acid levels correlate with the severity and the mortality of primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2312017

Long-Term Treatment of Primary Pulmonary Hypertension with Aerosolized Iloprost, a Prostacyclin Analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2312017

Bosentan therapy for pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2312017

Ventricular mass index using magnetic resonance imaging accurately estimates pulmonary artery pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2312017

Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2312017

Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2312017

21 January 2018

Identifiers

DOI

10.1164/RCCM.2312017

1 reference

6 December 2017

1 reference